All In Biotech

Investigational drug · Phase 3

BGB-B2033

Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Liver Cancer, Hepatocellular Carcinoma, Hepatocellular Cancer.

Phase 3

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

3

3 still active

All registered trials

3

Any phase or sponsor naming "BGB-B2033"

First trial start

2024

Jul 23, 2024

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "BGB-B2033", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Liver Cancer
  • Hepatocellular Carcinoma
  • Hepatocellular Cancer
  • Metastatic Hepatocellular Carcinoma
  • Local Advanced Hepatocellular Carcinoma
  • Alpha-fetoprotein (AFP)-Producing Gastric Cancer
  • Extragonadal Yolk Sac Tumors
  • Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer

Approved drugs for the same conditions: Non-small cell lung cancer · Small cell lung cancer · Liver cancer (hepatocellular carcinoma) · Stomach and esophageal cancer · Oncology · Gastroenterology and liver

Largest trials

Live from ClinicalTrials.gov: studies naming "BGB-B2033" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Liver Cancer

  • PM1009Phase 21 trial

    Biotheus Inc. · HCC, Liver Cancer

  • SL-28Phase 21 trial

    Second Life Therapeutics · Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from BeOne Medicines (BeiGene).

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.